Spain Crispr And Cas Genes Market Size & Outlook
Spain crispr and cas genes market, 2018-2030 (US$M)
Related Markets
Spain crispr and cas genes market highlights
- The Spain crispr and cas genes market generated a revenue of USD 88.9 million in 2024 and is expected to reach USD 182.4 million by 2030.
- The Spain market is expected to grow at a CAGR of 12.9% from 2025 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2024.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
Crispr and cas genes market data book summary
| Market revenue in 2024 | USD 88.9 million |
| Market revenue in 2030 | USD 182.4 million |
| Growth rate | 12.9% (CAGR from 2025 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
Other key industry trends
- In terms of revenue, Spain accounted for 1.9% of the global crispr and cas genes market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany crispr and cas genes market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 688.9 million by 2030.
Product was the largest segment with a revenue share of 86.84% in 2024. Horizon Databook has segmented the Spain crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
Numerous conferences and meetings related to CRISPR technology conducted in Spain have helped raise awareness among researchers & biotechnology companies, which is expected to boost market progression in the country.
The conference was attended by researchers, scientists, students, and business delegates, who shared & received knowledge about latest scientific advancements in CRISPR technology. Similarly, a debate titled The role of CRISPR in Personalized Medicine: Legal and Ethical Problems, conducted in December 2017, was attended by almost 400 attendees.
It highlighted the importance of CRISPR-Cas in applied research and discussed legal & ethical issues of genome editing in Spain. Such conferences & meetings can help expand the scope of CRISPR technology and overcome challenges of this technology.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR And Cas Genes Market Scope
CRISPR And Cas Genes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Spain crispr and cas genes market size, by product & service, 2018-2030 (US$M)
Spain CRISPR And Cas Genes Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
